Search

Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.

Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.

• Look Forward
• Audio
• Written

We were joined for this popular ‘Ask the expert’ session by Samantha de Silva, a consultant ophthalmic surgeon at Oxford Universities Hospital Trust.

• Webinar
• Audio
• Video

This is the only Half Marathon to be held at this historic royal home and Hampton Court Palace is one of only two surviving palaces that King Henry VIII owned. The race will start inside the Palace gates and finish in its beautiful gardens.

• Running
• London

Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.

• FAQ
• Written

“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”

• News

Simon spent 40 years as a consultant ophthalmic surgeon at the North Hampshire Hospital in Basingstoke.

• Trustee
• Written

These frequently asked questions should provide a response for most of the queries you might raise.

Researchers who received funding from Retina UK have carried out experimental gene therapy that is reported to have led to ‘life changing improvements’ to sight for four children with inherited sight loss.

• News
• Leber congenital amaurosis (LCA)

Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.

• Case study - research
• Written